Intravenous Immunoglobulin as a treatment for SLE with severe, refractory cutaneous involvement requiring hospitalization (Sengupta et al., 2023)

Supplemental Figures and Tables reporting patient demographics and clinical characteristics and dermatologic findings. Supplemental Figure 1. Acute cutaneous lupus erythematosus requiring hospitalization (Case 1). Supplemental Figure 2. Rapidly worsening DLE/SCLE before and after IVIg treatment (Case 2). Supplemental Figure 3. Acute cutaneous lupus erythematosus requiring hospitalization (Case 3). Supplemental Table 1. Patient summary and clinical characteristics.